Sangamo Therapeutics
SGMO
#10616
Rank
C$43.6 M
Marketcap
C$0.11
Share price
0.00%
Change (1 day)
-89.07%
Change (1 year)

P/S ratio for Sangamo Therapeutics (SGMO)

P/S ratio as of October 2026 (TTM): 0.8872

According to Sangamo Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.62. At the end of 2026 the company had a P/S ratio of 3.45.

P/S ratio history for Sangamo Therapeutics from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.45-7.5%
20253.73-59.62%
20249.241590.23%
20230.5467-88.17%
20224.62-53.15%
20219.87-47.15%
202018.797.06%
20199.48-31.78%
201813.9-63.36%
201737.9241.21%
201611.1-31.62%
201516.2-29.06%
201422.9-36.08%
201335.8143.29%
201214.71.97%
201114.4-0.28%
201014.520.63%
200912.036.26%
20088.81-84.73%
200757.796.7%
200629.3-40.88%
200549.6-56.97%
2004115117.86%
200352.9208.67%
200217.1-63.37%
200146.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.31 611.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
5.78 551.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
3.22 262.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
0.4998-43.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5.99 575.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.28 494.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
6.25 604.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.12 251.57%๐Ÿ‡บ๐Ÿ‡ธ USA